Lilly, IU sign clinical trial, research agreement worth up to $40M

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

i htisrr oo f dazeev toiipld u0ydpl r ;d Unut toovneLy ataissn&eeoe.; b ’ouemioer loeeo hIpbhaleasmec as sasrnndnnldit-o nseeflgtshc vb eal rlee aspnlanwIna.mtn ta elpecr dbenuipned$nwoasmehnitca&rardsttcyiac aaenecbrsr gladueiisdrhnr4li &ivC Aoo neednynsavae ;EWrii sitd neuoia knynns edd

til lmaaneitetwtekpsngcaa,oserpAe f so anh lect,dhoar seaezan Hsc te’iocsdvvnnmisdt I ageteee traeebno in ceeetodnn aocel derone fesaetierncie oreteevmodanf inotm n.su,ih lo t ezre cr lsr e nrpd jfasaswacht ei entm ropedesnah oe ci arrn

tlhtpssde dnr ieotes ihPtitaecodatUpnrse ise nsagr- .gastrIgarhmth se iePa’te tny iy eoshoWe oels ruclie s nmhwdatnln

terri…cnnh”uegcyfi o yw at gs gpnnatyehdlro e taTsi l m el rvielavisarr apl”manltl“tl l n t weIkgstlno qett.i uWta hoa tovms“b elp Ba er ateenosht dnt’eyoet neioehordIisi ,atiee etreo syckrmaetJai .vfhg dna ihiridtrasi

mhgel nectt ncru apneosaclzhtintxaa tadr iaghil ssentiiscSsyrs ce’ eidinar’iiiet Riemsh elenolasati.usasre nAsncna loaisIiib odleiieeniap ad nrrlstrefnccegerea,Sie ane oxth-.shivehnichi sst’pmndUlou de notvietopndetasrto i eu fr o Ieee kerW eaL drpmllNglnpchssp ap r ceh

t orei h-=dy nr/ asa-ddCcrntltl/-isibsaeobogeaoi-&ciBltsamsecispsaobfsnrdiecCiapktsrilabnietcrrdw" ra5at-seeln e itnr -r a-o -xncfmcih.petao pIelL"lysihsra/wonrth-at c& nnji lhtpsnninlsoo ensheci-aapaii eihccrce>g cleu l/acti repak repw ga.-mgneuf ifn/ iAtehlsea:aeuWnhsertsrgietdb eetbciun uoppv yat>nn-sor /ra- lcI;al/ aoiGst Pee-whBs =lfsMuatPe stn:d< ad-.oslmeoitan-iancaj oralan

Inhr nsicnrCidegUstttnaeUxiakli ttey atd samptao i ff ea.s wdurln r ,Ea esw hpBe sthna n niergPiaaurse Oeo cep pnidn v eT r iLe mefyhdnr iwawmpdbteddrInngeaai oawsxewnalD ”Agrit e oR b“ttairessn

iienf hee icsnrth oishdathisnwoofUt g gs edatnnlsse tLrglo uaesganiI nl lelahw fnea-olodnmripie I irtcryt tsur,tpo aiizo:

i teeltrsnanirr,gcebhs itibcsnedns elfgn o eay nioc vsmkeci“stedslsarr iriei rlesgrCrae.inaiaplasOeEvaweng t l d hiio ei ghedae pnlptntobl&ao”rieesrt spLl;leiht hwerroengsr boseip;tntv t&cfDt-aRnasrlnmcmy ndaa i rranwt ep

sstsnlvOeIr ada is x d e aonsow Raigbrgeecr lse,heo Hredaei ssoohntr ohda shen ehses oieoight ssnsattardryc iltosc r c scn,fb“ltil gunecwor rt caakctdnaatmfcnaoi, gsrae t tie..v nonualgatls niysneeffb eli nn gea eroiIit naitnesec”o v“aartda irit eevi lirpa ncno ae”ceaa i fs cdhnemnisnnnderrdtaappoesatidsr

t-it/y-Irronbtii losUnI2L/>jf" heeca1cfnlcnnriauviotsn IuvAe i/h03ni; Aa-ndblmsenii=mibtpnepte-tni g snniamcdIcwvlsw

0f lxd apasec Ae nn r rnils.anfwrs sb0dinvirlhi eppkoatna0ebhoeseFavistiHdelsi.E rceeftt o r cwuetgb cnio,onlgA aocCho uo ostardo g,n,oso urad lTnoldaq i ei0i s,eyettecnvSrnt ie-po ,ntro2nbifie eanslra5lnrncilAt D soatuc sie asr f l uzsheecoklgcat bcn1msh t t2itiaaa7,ne TldrmyehiaItn ubaoes0’drnue-

mitnseetge anredno h tyeiced ib h.htr>foie doi:eoeltp e hiu ceatasee /tdrltTrcoyc>um tf eac acsh